iA Global Asset Management’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.83M Sell
66,023
-220
-0.3% -$15.1K 0.06% 214
2026
Q1
$4.24M Sell
66,243
-187
-0.3% -$13K 0.06% 203
2025
Q4
$5.28M Buy
66,430
+918
+1% +$77.6K 0.07% 191
2025
Q3
$4.33M Buy
65,512
+65,190
+20,245% +$3.88M 0.06% 190
2025
Q2
$17K Buy
+322
New +$15.1K ﹤0.01% 411

Other funds holding IRON

iA Global Asset Management's IRON Position: Q2 2026 in Review

iA Global Asset Management reduced its Disc Medicine (IRON) stake by 0.33% in Q2 2026, selling an estimated $15.1K and leaving 66,023 shares worth $4.83M. The position accounts for 0.06% of the portfolio, ranked #214.

iA Global Asset Management first reported a position in IRON in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.28M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • iA Global Asset Management held 66,023 shares of Disc Medicine worth $4.83M as of Q2 2026.
  • iA Global Asset Management sold 220 Disc Medicine shares in Q2 2026, an estimated $15.1K.
  • Disc Medicine made up 0.06% of iA Global Asset Management's portfolio in Q2 2026, its #214 holding.
  • iA Global Asset Management first reported a position in Disc Medicine in Q2 2025 and has held it in 5 quarters since.
  • iA Global Asset Management's Disc Medicine position peaked at $5.28M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.